Rheumatoid Arthritis and Cancer Risk

Author： Mellemkjaer L.   Linet M.S.   Gridley G.   Frisch M.   Moller H.   Olsen J.H.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.10, 1996-09, pp. : 1753-1757

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan

By Yau Thomas   Chu Kin   Mok Mo   Liang Raymond   Epstein Richard  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 771-772

Informa Healthcare

Access to resources Recommend Favorite

Rheumatoid Arthritis—Progress, At Last, Is In Hand

By  

The Genesis Report - Rx, Vol. 8, Iss. 5, 1999-08 ,pp. : 25-30

Adis International

Access to resources Recommend Favorite

Chemokines and chemokine receptors in rheumatoid arthritis

By Szekanecz Z.   Kim J.   Koch A.E.  

Seminars in Immunology, Vol. 15, Iss. 1, 2003-02 ,pp. : 15-21

Academic Press

Access to resources Recommend Favorite

Role of basophils in rheumatoid arthritis (Review)

By                      

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1567-1571

Spandidos Publications

Access to resources Recommend Favorite

Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis

By Neeck Gunther  

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 2, 2002-12 ,pp. : 61-69

Informa Healthcare

Access to resources Recommend Favorite